Summit

FT Global Pharmaceutical and Biotech Summit

Name: FT Global Pharmaceutical and Biotech Summit
Location: London, UK

An elite strategic summit bringing together pharmaceutical CEOs, policy makers, and investors to debate life science commercialization.

When: November, Early November
Where: London, UKView on Google Maps
Format: Hybrid
Organiser: Financial Times
Region: Europe
Scale: About 500 attendees
Founded: 2018

The Signal

The FT Global Pharmaceutical and Biotech Summit is a high-level executive conference hosted by the Financial Times. The event focuses on the commercial, political, and clinical forces shaping the pharmaceutical and biotechnology sectors. For life science investors and drug development tech vendors, it provides essential context on market access and drug pricing.

What to expect

Drug pricing reform debates
Pharmaceutical research and development pipeline priorities
Biotech market consolidation and mergers and acquisitions activity

Who is in the room

Pharmaceutical chief executive officers, biotechnology founders, life science investors, and health policy makers attend.

Background

The Financial Times established this summit to bring their trademark analytical rigour to the life sciences sector. It has grown into one of the most prominent strategic forums for pharmaceutical leadership in Europe.

Official event site